Image credit: Jeremy Buckingham

Advil-Maker GlaxoSmithKline Among Entities Newly Lobbying on Cannabis

From CBD and banking legislation in Congress to the right to advertise in legal states, here are the entities newly lobbying on cannabis-related issues at the national level.

Lobbying
Regulation

National Academies’ Cannabis Committee Convenes Again

The second meeting of the Committee on the Public Health Consequences of Changes in the Cannabis Policy Landscape is underway this week. Here’s what happened on day one.